How do I hire a part-time CRO for a medtech company in 2027?
Direct Answer
Hiring a part-time CRO for medtech in 2027 means finding a seasoned revenue executive who understands the unique constraints of medical device or diagnostic sales — long regulatory timelines, multi-stakeholder hospital purchasing committees, and the need to balance clinical evidence with commercial viability. A fractional CRO is not a cheaper substitute for a full-time hire; it is a strategic deployment of experienced leadership for companies that cannot yet justify a $250,000+ base salary plus benefits. You pay for outcomes and pattern recognition, not for a warm body in a chair. The cost range above assumes a cash-only arrangement; adding 1-3% equity can reduce monthly cash outlay by 20-30%.
Why Medtech Is Different from Other Fractional CRO Engagements
Medtech sales in 2027 are not SaaS sales with a lab coat. The buying committee includes surgeons, hospital administrators, procurement officers, clinical engineers, and sometimes ethics board members. Each stakeholder has a different veto power. A fractional CRO who has only sold subscription software will fail to navigate these dynamics because they lack the vocabulary and relationship map. You need someone who can walk into a hospital and talk about clinical outcomes, reimbursement codes, and OR workflow efficiency in the same conversation.
The regulatory environment adds another layer. Medtech companies often face 510(k) clearance timelines of 3-12 months, PMA pathways of 12-24 months, and post-market surveillance requirements. A fractional CRO must understand how these timelines affect revenue forecasting, sales compensation, and investor communication. They should be able to explain why your Q4 revenue projection is unrealistic given that your product is still awaiting CE marking.
How to Evaluate a Fractional CRO Candidate
Start with their deal history. Ask for three specific examples of medtech deals they have closed, including the stakeholder map, the sales cycle length, and the pricing structure. Listen for specifics — "We sold a $200,000 capital system to a 300-bed hospital" is better than "I have experience in medtech." Do not accept generic references from non-medtech roles.
Assess their network. A good fractional CRO for medtech should have warm relationships with at least a few hospital systems, GPOs, or distributor partners. They should be able to pick up the phone and get you a meeting with a decision-maker within two weeks. If they cannot, they are a strategist, not a revenue leader — and you may still need that, but be clear about it.
Test their regulatory fluency. Ask them to explain how FDA clearance milestones affect sales territory assignments or how reimbursement codes influence pricing. A candidate who cannot articulate this will cost you time and credibility with clinical buyers.
Where to Find Fractional CROs for Medtech
Pavilion (joinpavilion.com) has a dedicated community of revenue leaders, many with medtech backgrounds. You can post a role or search member directories. RevOps Co-op (revopscoop.com) is another strong network, particularly for candidates who understand the operational side of medtech sales. LinkedIn remains the largest pool, but you must filter aggressively. Search for terms like "fractional CRO medtech," "VP of Sales medical devices," or "commercial leader diagnostics." Look for profiles that list specific companies like Stryker, Medtronic, Boston Scientific, or smaller medtech exits.
Structuring the Engagement for Success
Define the engagement in writing with clear deliverables. A good fractional CRO agreement should include:
- Days per week and core hours. Medtech sales often require travel to hospitals or trade shows. Clarify whether travel days count as full engagement days.
- Meeting cadence. Weekly pipeline reviews, monthly board updates, and quarterly strategy sessions are standard.
- Communication channels. Will they use Slack, email, or your CRM? Do they have access to Gong or Clari for call analysis and forecasting?
- Off-ramp terms. A 30-day notice period is typical. Some agreements include a 90-day minimum commitment with a mutual opt-out after that.
- Non-compete and confidentiality. Medtech product roadmaps and clinical data are sensitive. Ensure your agreement includes standard protections.
Do not over-engineer the contract. Fractional engagements work best when both parties trust each other. A 2-3 page letter of agreement is often sufficient.
Common Mistakes When Hiring a Fractional CRO for Medtech
Mistake 1: Hiring for general sales experience instead of medtech domain. A CRO who has scaled a $50M SaaS company may still fail in medtech because they do not understand the clinical buying process. The cost of this mistake is 6-12 months of lost time and damaged customer relationships.
Mistake 2: Under-scoping the engagement. One day per week is rarely enough for a medtech company with a complex sales cycle. You need at least two days for pipeline management, stakeholder meetings, and internal alignment. Three days is better if you are pre-revenue and need market strategy.
Mistake 3: Ignoring the regulatory timeline. Do not hire a fractional CRO who promises aggressive revenue targets without understanding your FDA clearance or CE marking schedule. A realistic medtech revenue plan accounts for regulatory milestones, not just sales activity.
Mistake 4: Skipping the trial period. Always start with a 90-day trial with clear milestones. This protects both sides and allows you to assess cultural fit and domain competence before committing to a longer engagement.
FAQ
What specific medtech experience should a fractional CRO have? They should have direct experience with your product class (capital equipment, consumables, diagnostics, or digital health) and familiarity with the regulatory pathway your product follows (510(k), PMA, or CE marking). They should also understand hospital value analysis committees and GPO contracting.
Can a fractional CRO work with a pre-revenue medtech company? Yes, but the focus shifts from closing deals to building the commercial strategy, identifying early adopter sites, and preparing for regulatory approval. Expect the CRO to spend more time on market research and KOL engagement than on direct sales.
How do I handle equity in a fractional CRO arrangement? Equity is common for fractional CROs at pre-revenue or early-stage companies. Typical ranges are 1-3% vesting over 3-4 years with a one-year cliff. This reduces monthly cash cost by 20-30%. For later-stage companies ($2M+ ARR), cash-only arrangements are more common.
What tools should a fractional CRO use in medtech? They should be proficient in Salesforce or HubSpot for CRM, Gong or Clari for revenue intelligence, and Outreach or Salesloft for sales engagement. They should also be comfortable with medtech-specific tools like Definitive Healthcare or IQVIA for market intelligence.
How quickly can a fractional CRO impact medtech revenue? Realistic impact takes 3-6 months for early-stage companies and 1-3 months for companies with existing pipeline. Medtech sales cycles are long, so do not expect immediate closed-won deals. Look for leading indicators like pipeline velocity, meeting conversion, and stakeholder engagement.
Should I hire a fractional CRO or a full-time VP of Sales? Hire fractional if you are pre-revenue to $5M ARR, have a complex sales cycle, or cannot afford a full-time executive. Hire full-time if you have $5M+ ARR, a proven sales process, and need dedicated daily leadership.